1. US Food and Drug Administration. New molecular entity approvals for 2011. Washington, DC: US Department of Health & Human Services. Available at: http://www.fda.gov/drugs/developmentapprovalprocess/drugInnovation/ucm285554.htm. Accessed March 30, 2015.
2. US Food and Drug Administration. New molecular entity approvals for 2012. Washington, DC: US Department of Health & Human Services. Available at: http://www.fda.gov/drugs/developmentapprovalprocess/drugInnovation/ucm336115.htm. Accessed March 30, 2015.
3. US Food and Drug Administration. New molecular entity approvals for 2013. Washington, DC: US Department of Health & Human Services. Available at: http://www.fda.gov/drugs/developmentapprovalprocess/drugInnovation/ucm381263.htm. Accessed March 30, 2015.
4. Teratogenicity of recently introduced medications in human pregnancy;Lo;Obstet Gynecol,2002
5. Evolving knowledge of the teratogenicity of medications in human pregnancy;Adam;Am J Med Genet C Semin Med Genet,2011